Abiopharma

New Form N-PX - BLACKROCK DEBT STRATEGIES FUND, INC. <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001438934-26-002374 <b>Size:</b> 19 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director - Chong Juin Kuan

(10% Negative) BIOATLA, INC. (BCAB) Announces Clinical Trial Timeline Adjustment

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001193125-26-372882 <b>Size:</b> 994 KB

(95% Positive) SCIENCE APPLICATIONS INTERNATIONAL CORP (SAIC) Reports Q3 2026 Financial Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025277 <b>Size:</b> 1 MB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042119 <b>Size:</b> 520 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025276 <b>Size:</b> 651 KB

Klarna CEO Sebastian Siemiatkowski Acquires 692,506 Shares for $10 Million

BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement

Keysight Technologies Announces Participation in Upcoming Investor Conferences

Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Holley Securities Litigation

BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement

Nano Labs Announces First Half of 2026 Financial Results

Black Rock Coffee Bar Continues Expansion in Arizona with new Tucson Location